支气管肺癌56例临床治疗研究

Clinical therapy observation of 56 cases of bronchopulmonary carcinoma

目的探讨56例支气管肺癌患者临床治疗情况,并且总结分析临床治疗效果。方法选取在笔者所在呼吸内科2010年1月～2011年1月期间治疗的56例支气管肺癌患者为实验组,亦选择同时期56例支气管肺癌患者为常规组。实验组选用易瑞沙治疗;常规组选用常规化疗方案。结果实验组的56例患者在院治疗期间,无效4例,无效率为7.1%;有效3例,有效率5.4%,49例患者治疗显效出院,总有效率87.5%。常规组无效10例,无效率为17.9%;有效6例,有效率10.71%;显效40例,总有效率71.42%。结论对于支气管肺癌的治疗,早期选用易瑞沙治疗,效果较好。

Objective To discuss the clinical therapeutic state of 56 cases of bronchopulmonary carcinoma, and to summarize and analyze the clinical therapeutic effect. Methods The clinical date of 56 cases of bronchopulmonary carcinoma patients who were admitted into respiratory medicine department of our hospital for therapy from Jan.2010 to Jan.2011 was selected; meanwhile, 56 cases ofbronchopnlmonary carcinoma patients were selected. The experimental group was treated with Iressa, the normal-care group was treated with routine chemotherapy. Results During the treatment, the 56 cases of patients of experimental group, 4 cases were relapsed, recurrence rate was 7.1%; 3 cases were displaced, metastasis rate was 5.4%, the other patients leaved from hospital due to recovery, the overall response rate was 87.5%. 10 cases of normal-care group were relapsed, recurrence rate was 17.9%; 6 cases were displaced, metastasis rate was 10.71%; 40 cases were recovered, the overall response rate was 71.42%. Conclusion It has a good effect when use the Iressa early in the treatment of bronchopulmonary carcinoma.